Associated Papers
Expanded targeting scope of LbCas12a variants allows editing of multiple oncogenic mutations.
Choi E et al.
Molecular Therapy. Nucleic Acids, 2022
Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing.
Kleinstiver BP et al.
Nature Biotechnology, 2019
30742127 (PubMed )
Supplement: NIHMS1517348-supplement-11.xlsx › P_values
Engineered Cpf1 variants with altered PAM specificities.
Gao L et al.
Nature Biotechnology, 2017
Select a paper to view details